Transitional Year

HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Citrus Hospital Program

Inverness, FL · South Atlantic

🌍 J-1 VisaPreliminaryRuralHospitalistWomen's Health
YOUR FIT· HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Citrus Hospital Program

Create a free profile to see your personalized fit

Get Started

Contact

JA
Program Director
John Abernathy, DO, MBA
Email director
CL
Program Coordinator
Claire Lynch, MD
Email coordinator
Program website

Training Sites

3 hospitals in Inverness

  • 1
    HCA Florida Citrus Hospital
    Inverness, FL
    Primary
  • 2
    HCA Florida Healthcare/USF Morsani College of Medicine GME
    Tampa, FL
    Sponsor
  • 3
    Citrus Preferred Clinic
    Inverness, FL
    Participant

Score Ranges

USMLE Step 2 CK235 – 265
180205230255280
COMLEX Level 2 CE478 – 679
400500600700800

Interview Rates

US MD
0%
US DO
60%
US IMG
0%
Non-US IMG
1%

Applicant Origin

In-State
22%
Out-of-State
12%

Similar Programs

Boston Medical Center-Brighton ProgramJamaica Plain, MA
233–267
HCA Florida Healthcare/Aventura Hospital ProgramAventura, FL
237–263
HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa North/Oak Hill Hospital ProgramBrooksville, FL
237–263
HCA Florida Healthcare/Westside/Northwest Hospital ProgramPlantation, FL
233–267
Medical College of Wisconsin Affiliated Hospitals ProgramMilwaukee, WI
233–267

Interview Prep

Common questions for Transitional Year interviews

personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common

Related

View all Transitional Year programsCalculate your match probabilityIMG-Friendly Programs

Calculate your match probability for Transitional Year

See how your profile compares across all programs

Open Calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.